COSMOS Pharmaceutical Revenue

COSMOS Pharmaceutical had revenue of 244.10B JPY in the quarter ending November 30, 2024, with 3.97% growth. This brings the company's revenue in the last twelve months to 994.50B, up 10.49% year-over-year. In the fiscal year ending May 31, 2024, COSMOS Pharmaceutical had annual revenue of 964.99B with 16.59% growth.

Revenue (ttm)

994.50B

Revenue Growth

+10.49%

P/S Ratio

0.59

Revenue / Employee

180.42M

Employees

5,512

Market Cap

590.94B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
May 31, 2024	964.99B	137.29B	16.59%
May 31, 2023	827.70B	72.28B	9.57%
May 31, 2022	755.41B	28.99B	3.99%
May 31, 2021	726.42B	42.02B	6.14%
May 31, 2020	684.40B	73.27B	11.99%
May 31, 2019	Pro	Pro	Pro
May 31, 2018	Pro	Pro	Pro
May 31, 2017	Pro	Pro	Pro
May 31, 2016	Pro	Pro	Pro
May 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Chugai Pharmaceutical	1,142.35B
Daiichi Sankyo Company	1,758.07B
HOYA Corporation	812.74B
Takeda Pharmaceutical Company	4,546.08B
Otsuka Holdings	2,269.56B
Terumo	986.67B
Astellas Pharma	1,772.16B
Olympus	973.60B

Revenue Rankings